Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40002438
Localisation
India
Asia
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
04/12/2025
Statut
Classification
1.5°C
Année cible
FY2033
Near-Term Targets: Lupin Ltd commits to reduce absolute scope 1 and 2 GHG emissions 42.0% by FY2030 from a FY2023 base year.* Lupin Ltd also commits to reduce scope 3 GHG emissions from purchased goods and services, fuel- and energy-related activities, upstream transportation and distribution, business travel, employee commuting, downstream transportation and distribution, processing of sold products, use of sold products and franchises 61.07% per INR value added by FY2033 from a FY2024 base year. *The target boundary includes land-related emissions and removals from biogenic feedstocks.
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
ISIN
INE326A01037
LEI
335800HHXTESDEE2FC65
Source : Science Based Targets initiative | Données publiques